Kyorin Pharmaceutical
4569.TPharmaceutical
Filed as KYORIN Holdings, Inc. (2022-06–2022-06), KYORIN Holdings,Inc. (2022-08–2023-02)
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥110.9bn | ¥115.9bn | ¥105.2bn | ¥5.9bn | ¥6.6bn | ¥7.2bn |
| Operating income | ¥4.3bn | ¥12.9bn | ¥6.9bnr | ¥3.1bn | ¥4.0bn | ¥4.7bn |
| Ordinary income | ¥5.0bn | ¥13.7bn | ¥7.6bnr | ¥3.0bn | ¥4.0bn | ¥4.6bn |
| Total assets | ¥176.7bn | ¥179.7bn | ¥163.5bnr | ¥99.3bn | ¥95.6bn | ¥95.4bn |
| Net assets / equity | ¥127.9bn | ¥125.3bn | ¥119.4bnr | ¥64.9bn | ¥65.0bn | ¥64.8bn |
| EPS (basic) | ¥72.82 | ¥163.29 | ¥925.92r | ¥51.78 | ¥67.51 | ¥77.8 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 196 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 196 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 196 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 196 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 196 figures · EDINET |
21 more reports are still being processed.